Inotiv | analyze. answer. advance.
  • About
    • Why Inotiv
    • Leadership
    • News
    • Events
    • Regulatory Compliance
    • Our Commitment to Integrity and Ethical Conduct
  • Services
    • Research and Discovery
      • Computational Toxicology
      • Disease Pharmacology (in vitro and in vivo)
      • DMPK (in vitro and in vivo)
      • Safety Pharmacology
      • Cell and Molecular Biology
      • Discovery Bioanalysis
        • Biomarkers
      • Exploratory Toxicology
        • Toxicogenomics
        • Genetic Toxicology
        • General Toxicology
      • Surgical Models and Medical Device
    • Nonclinical Safety Assessment
      • General Toxicology
      • Safety Pharmacology
      • Genetic Toxicology
      • Regulated Bioanalysis
      • — Biotherapeutics
        • Biomarker
      • DMPK (PK/TK)
      • Developmental and Reproductive Toxicology
      • Carcinogenicity Studies
      • Surgical Models and Medical Device
    • Pathology
      • Histology
      • Digital Pathology
      • Clinical Pathology
      • Medical Device Pathology
    • Bioanalysis
      • Nonregulated Discovery Bioanalysis
      • Regulated Preclinical and Clinical Bioanalysis
      • Biotherapeutics
        • Biomarkers
    • Proteomics
    • Consulting
    • Research Models and Services
  • Insights
  • Contact
  • |
  • Investors
  • Careers
  • VISIT OUR VIRTUAL BOOTH

2022

Press Release

December 12, 2022

Inotiv, Inc. Provides Business Update and Select Preliminary Fiscal Year 2022 Financial Results

Press Release

December 8, 2022

Inotiv, Inc. Announces New Site Openings and Expansions Supporting Additional Capacity and Service Offerings

Press Release

November 29, 2022

Inotiv, Inc. Announces Additional Site Consolidation Plan in the U.S., Intent to Consult with Employee Representatives for a Proposed Consolidation of Certain European and U.K. Sites, and Update on Site Optimization Plans in Process

Press Release

November 28, 2022

Inotiv, Inc. to Report Fourth Quarter Fiscal 2022 Financial Results and Host Conference Call on Monday, December 12, 2022

Corporate News

November 1, 2022

Inotiv Announces Brennan Freeman as Vice President, Finance and Corporate Controller

Press Release

November 1, 2022

Inotiv, Inc. to Participate in November Investor Conferences

Corporate News

September 21, 2022

Inotiv Announces Matt Vaneman as Vice President, Operational Excellence

Corporate News

September 8, 2022

Inotiv Announces Dr. Harutyun Avsaroglu as Executive Director, Global Laboratory Animal Resources

Press Release

August 31, 2022

Inotiv, Inc. to Participate in September Investor Conferences

Press Release

August 10, 2022

Inotiv, Inc. Announces Third Quarter Fiscal 2022 Financial Results—Increases Select Fiscal Year 2022 Financial Guidance

Posts navigation

Older posts
Get the Insights You Deserve

Answering the right questions on time and with high-quality data is the key to achieving your objectives. Expect more.

Get In Touch
Inotiv Logo

2701 Kent Avenue
West Lafayette, IN 47906 USA
800.845.4246
765.463.4527

Copyright © 2023 Inotiv. All Rights Reserved.

  • Privacy
  • Accessibility
  • Terms Of Use
  • Contact
  • About
    • Why Inotiv
    • Leadership
    • News
    • Events
    • Regulatory Compliance
    • Our Commitment to Integrity and Ethical Conduct
  • Services
    • Research and Discovery
      • Computational Toxicology
      • Disease Pharmacology (in vitro and in vivo)
      • DMPK (in vitro and in vivo)
      • Safety Pharmacology
      • Cell and Molecular Biology
      • Discovery Bioanalysis
        • Biomarkers
      • Exploratory Toxicology
        • Toxicogenomics
        • Genetic Toxicology
        • General Toxicology
      • Surgical Models and Medical Device
    • Nonclinical Safety Assessment
      • General Toxicology
      • Safety Pharmacology
      • Genetic Toxicology
      • Regulated Bioanalysis
      • — Biotherapeutics
        • Biomarker
      • DMPK (PK/TK)
      • Developmental and Reproductive Toxicology
      • Carcinogenicity Studies
      • Surgical Models and Medical Device
    • Pathology
      • Histology
      • Digital Pathology
      • Clinical Pathology
      • Medical Device Pathology
    • Bioanalysis
      • Nonregulated Discovery Bioanalysis
      • Regulated Preclinical and Clinical Bioanalysis
      • Biotherapeutics
        • Biomarkers
    • Proteomics
    • Consulting
    • Research Models and Services
  • Insights
  • Contact
  • |
  • Investors
  • Careers
  • VISIT OUR VIRTUAL BOOTH